9265.T
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.
Business. The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥5.698 billion, representing 20.7% of total assets. The absence of long-term debt and a debt-to-equity ratio of 0.0 indicate a conservative capital structure. The current ratio of 1.2 suggests adequate short-term liquidity to cover current liabilities.
Profitability metrics show a return on equity (ROE) of 6.86% and a return on assets (ROA) of 2.24%. These figures are below the industry median for ROE and ROA, indicating that the company's profitability is lagging relative to its peers. The operating margin is 1.35%, and the net profit margin is 0.95%, both of which are below the industry median, suggesting that the company is underperforming in terms of cost control and pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of different parts of the business.
The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The operating cash flow of ¥618 million and free cash flow of ¥355 million indicate a stable but not robust cash generation capability. The capital expenditure of ¥310 million suggests a moderate investment in future growth.
Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of long-term debt and a strong cash position mitigate liquidity risk. However, the company's reliance on a single business segment and lack of geographic diversification pose concentration risks.
Recent events include the latest actual EPS of 249.47 JPY and actual revenue of ¥64.486 billion JPY, as reported by analysts. No significant recent filings or transcripts have been disclosed that would indicate major strategic shifts or operational changes.
- The company has a conservative capital structure with no long-term debt and a strong cash position.
- Profitability metrics are below industry medians, indicating underperformance in terms of ROE and ROA.
- The company's revenue is concentrated in a single business segment, increasing exposure to regional and regulatory risks.
- Growth is modest, with stable but not robust cash generation capabilities.
- Risk factors are low, with no immediate liquidity or dilution concerns.
- "margin_outlook_rationale": "The company's operating and net profit margins are below industry medians, indicating potential inefficiencies in cost management and pricing power.",
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 9265.T Market data — financials · 2026-05-27
- Yamashita Health Care Holdings Inc Market data — analyst estimates · 2026-05-27